Table 1. Patient, donor, and... | American Society of Hematology

Table 1.

Patient, donor, and transplantation characteristics

Characteristic	No. of patients
No. of patients	154
Median patient age, y (range)	17 (1-46)
Median donor age, y (range)	33 (21-53)
Sex (male/female)
Patient	86/68
Donor	93/61
Patient/donor sex
Male/male	58
Female/female	33
Male/female	28
Female/male	35
Etiology of aplastic anemia
Idiopathic	147
Hepatitis	6
Drug	1
Disease duration before BMT
1 y or less	26
1-3 y	52
3 y or more	73
Unknown	3
RBC transfusions before BMT
Less than 20	30
20 or more	112
Unknown	12
Platelet transfusions before BMT
Less than 20	31
20 or more	109
Unknown	14
GVHD prophylaxis
CSA/MTX	113
Tacrolimus/MTX	21
Others	20
Marrow cell dose
Less than 3 × 10⁸/kg	36
3 × 10⁸/kg or more	78
Unknown	40
Conditioning regimen
TBI + CY + ATG	56
LFI + CY + ATG	26
TBI + CY	51
LFI + CY	13
Others	8

Characteristic	No. of patients
No. of patients	154
Median patient age, y (range)	17 (1-46)
Median donor age, y (range)	33 (21-53)
Sex (male/female)
Patient	86/68
Donor	93/61
Patient/donor sex
Male/male	58
Female/female	33
Male/female	28
Female/male	35
Etiology of aplastic anemia
Idiopathic	147
Hepatitis	6
Drug	1
Disease duration before BMT
1 y or less	26
1-3 y	52
3 y or more	73
Unknown	3
RBC transfusions before BMT
Less than 20	30
20 or more	112
Unknown	12
Platelet transfusions before BMT
Less than 20	31
20 or more	109
Unknown	14
GVHD prophylaxis
CSA/MTX	113
Tacrolimus/MTX	21
Others	20
Marrow cell dose
Less than 3 × 10⁸/kg	36
3 × 10⁸/kg or more	78
Unknown	40
Conditioning regimen
TBI + CY + ATG	56
LFI + CY + ATG	26
TBI + CY	51
LFI + CY	13
Others	8

RBC indicates red blood cell.